Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Walmart, the nation's largest private employer, is expanding nationwide its health care coverage next month for employees who want to enlist the services of a doula, a person trained to assist women during pregnancies.
A group of 33 states including California and New York are suing Meta Platforms Inc. for harming young people’s mental health and contributing the youth mental health crisis by knowingly designing features on Instagram and Facebook that addict children to its platforms.
In a courtroom showdown five years in the making, Donald Trump's fixer-turned-foe Michael Cohen testified Tuesday that he worked to boost the supposed value of the former president's assets to “whatever number Trump told us to."
Federal authorities have released more details and unsealed charges in the theft of more than 2 million dimes earlier this year from a tractor-trailer that had picked up the coins from the U.S. Mint in Philadelphia.
